Hongcheng Zhu: Global collaboration to close the gap in radiotherapy accessibility
Hongcheng Zhu, Radiation Oncologist at Fudan University Shanghai Cancer Center, China, shared a post by The Lancet on X, adding the following:
“Super great team work of such an important topic led by May Wahab and Andrew. Thanks for bringing us together, brainstorming for closing the gap of radiotherapy & theranostics accessibility globally.”
Quoting The Lancet:
“Radiotherapy is a crucial component of cancer care, yet global access to services, as well as the promising field of theranostics, remains a major problem.
A new The Lancet Oncology Commission assesses the current state of access to radiotherapy and theranostics at a global level.
It is estimated that 50–70% of all patients with cancer worldwide need radiotherapy, with more than 50% of this population residing in low-income and middle-income countries (LMICs).
Authors propose key actions and investments to increase access to imaging, diagnostic, and therapeutic radiopharmaceuticals, and radiotherapy.”
Source: Hongcheng Zhu/X and The Lancet/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023